Found 7 matching trials
Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD5004 PHASE1 This is a Phase I, multicentre, single-dose, non-randomised, open-label, pa...
Show More Learn More & Join Trial
A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus PHASE3 The purpose of this study is to evaluate the efficacy and safety of elecogl...
Show More Learn More & Join Trial
FTIH of ECC5004 in Healthy and Diabetic Participants PHASE1 This is a Phase 1, randomized, double-blind, placebo-controlled, single asc...
Show More Location
Eccogene Investigational Site
Learn More & Join Trial
A Phase I Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD5004 PHASE1 This is a Phase I, multicentre, single-dose, non-randomised, open-label, pa...
Show More Learn More & Join Trial
ECC5004 RBA FE Study in Healthy Participants PHASE1 This study is a Phase 1, open-label, randomized, single dose, fixed sequenc...
Show More Location
Eccogene Investigational Site
Learn More & Join Trial
A Study to Investigate Multiple Ascending Doses and Relative Bioavailability of AZD5004 in Healthy Participants PHASE1 The main purpose of this study is to assess the safety, tolerability, and p...
Show More Learn More & Join Trial
ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants PHASE1 This is a Phase 1, open-label, non-randomized, fixed sequence study designe...
Show More Location
Eccogene Investigational Site
Learn More & Join Trial